GlassScriptPhysician profile
Keith L Lee
NPI 1114036142
$3,177.11
in general payments reported to CMS, 2019-2025
10 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $204 · 2022: $263 · 2023: $2,302 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,250 · Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,250.00 |
| Food and Beverage | $313.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $2,516.38 | 2022-2025 | Aquabeam Robotic System |
| Boston Scientific Corporation | $189.56 | 2020-2025 | Spaceoar Vue System - 10ml |
| Pfizer INC. | $146.43 | 2019-2020 | |
| Intuitive Surgical, INC. | $116.42 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.89 | 2022 | |
| Valencia Technologies Corporation | $49.24 | 2025 | Ecoin Device Kit |
| 180 Medical, INC. | $40.71 | 2020 | |
| Lilly USA, LLC | $28.25 | 2025 | Mounjaro, Zepbound |
| Allergan, INC. | $16.98 | 2020 | |
| Medtronic, INC. | $16.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.